Next Article in Journal
Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts
Previous Article in Journal
The Role of Routine Culture in the Treatment of Chronic Suppurative Otitis Media: Implications for the Standard of Care in Rural Areas of South Africa
Previous Article in Special Issue
Phylogeography of Bulinus truncatus (Audouin, 1827) (Gastropoda: Planorbidae) in Selected African Countries
Article Menu

Export Article

Open AccessOpinion
Trop. Med. Infect. Dis. 2019, 4(1), 11; https://doi.org/10.3390/tropicalmed4010011

WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis

BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA
*
Author to whom correspondence should be addressed.
Received: 30 November 2018 / Revised: 26 December 2018 / Accepted: 2 January 2019 / Published: 9 January 2019
(This article belongs to the Special Issue Prospects for Schistosomiasis Elimination)
Full-Text   |   PDF [279 KB, uploaded 9 January 2019]

Abstract

Schistosomiasis is an acute and chronic disease that affects over 200 million people worldwide, and with over 700 million people estimated to be at risk of contracting this disease, it is a pressing issue in global health. However, research and development (R&D) to develop new approaches to preventing, diagnosing, and treating schistosomiasis has been relatively limited. Praziquantel, a drug developed in the 1970s, is the only agent used in schistosomiasis mass drug administration (MDA) campaigns, indicating a critical need for a diversified therapeutic pipeline. Further, gaps in the vaccine and diagnostic pipelines demonstrate a need for early-stage innovation in all areas of schistosomiasis product R&D. As a platform for public-private partnerships (PPPs), the WIPO Re:Search consortium engages the private sector in early-stage R&D for neglected diseases by forging mutually beneficial collaborations and facilitating the sharing of intellectual property (IP) assets between the for-profit and academic/non-profit sectors. The Consortium connects people, resources, and ideas to fill gaps in neglected disease product development pipelines by leveraging the strengths of these two sectors. Using WIPO Re:Search as an example, this article highlights the opportunities for the PPP model to play a key role in the elimination of schistosomiasis. View Full-Text
Keywords: schistosomiasis; neglected tropical diseases; WIPO Re:Search; BIO Ventures for Global Health; cross-sector collaboration; capacity-building; drug discovery; public-private partnerships schistosomiasis; neglected tropical diseases; WIPO Re:Search; BIO Ventures for Global Health; cross-sector collaboration; capacity-building; drug discovery; public-private partnerships
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Weber, C.J.; Hargan-Calvopiña, J.; Graef, K.M.; Manner, C.K.; Dent, J. WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis. Trop. Med. Infect. Dis. 2019, 4, 11.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Trop. Med. Infect. Dis. EISSN 2414-6366 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top